Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports - Reuters

Reuters | Sept. 12, 2020, 3:28 p.m. | Original
Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports Reuters
France's daily COVID-19 cases pass 10,000 for first time - Reuters UK Soccer-Klopp hails his champions and Leeds for 'proper spectacle' - Reuters Africa